#

AstraZeneca

: 15
Shares of AstraZeneca, a British biopharmaceutical giant, fell nearly 7%. Photo: Mats Wiklund/Shutterstock
News·
AstraZeneca shares plummeted following news of a mega-deal with Bristol Myers
Trumps announcement of new negotiations with Iran has boosted market optimism regarding a potential resumption of shipping through the Strait of Hormuz / Photo: Shutterstock.com
Review·
Top Stories This Morning: U.S.-Iran Talks, a Major Pharmaceutical Deal, and a Market Correction in Asia
Profits at British pharmaceutical giant AstraZeneca exceeded analysts expectations last quarter. Photo: Konektus Photo/Shutterstock
News·
Oncology drugs helped boost AstraZeneca's profits by 21%. Will the company expand its portfolio?
The main risk associated with the failure of the trials is a “potential loss of confidence” in the company, according to Jefferies: based on their information, AstraZeneca’s management was confident in the effectiveness of the drug’s development / Photo: Declan Sun / unsplash
News·
AstraZeneca lost $27 billion in market capitalization in a single day: its drug failed clinical trials
Coca-Colas earnings report will be one of the key ones this week for Wall Street / Photo: Shutterstock.com
News·
US inflation, Ferrari and Coca-Cola earnings: what investors need to know this week
Nine major pharma companies have made deals with Trump to lower drug prices
News·
Nine major pharma companies have made deals with Trump to lower drug prices
U.S. to reach drug pricing agreements with Novartis and Roche - Bloomberg
News·
U.S. to reach drug pricing agreements with Novartis and Roche - Bloomberg
Morning in New York: Fed rhetoric and corporate reporting in focus
News·
Morning in New York: Fed rhetoric and corporate reporting in focus
AstraZenecas drug has produced positive results in the fight against breast cancer. What about the stock?
News·
AstraZeneca's drug has produced positive results in the fight against breast cancer. What about the stock?
AstraZeneca to float in New York but retain London listing
News·
AstraZeneca to float in New York but retain London listing
Pharma stocks in Europe reacted weakly to Trumps threats of new duties
News·
Pharma stocks in Europe reacted weakly to Trump's threats of new duties
Cohens Shield: 10 stocks the Point72 founder uses to protect his portfolio from overheating
News·
Cohen's Shield: 10 stocks the Point72 founder uses to protect his portfolio from overheating
Load more